STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[IRANNOTICE] LivaNova PLC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
IRANNOTICE





image_0.jpg



U.S. Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549

November 5, 2025

Re: Notice of Disclosure Filed in Exchange Act Quarterly Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934

Ladies and Gentlemen:

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that LivaNova PLC has made disclosure pursuant to those provisions in its Quarterly Report on Form 10-Q for the period ended September 30, 2025, which was filed with the Securities and Exchange Commission on November 5, 2025. The disclosure can be found within Part II, Item 5. Other Information in the Quarterly Report on Form 10-Q.


Respectfully submitted,

LivaNova PLC


By:/s/ VLADIMIR MAKATSARIA
Vladimir Makatsaria
Chief Executive Officer


By:/s/ ALEX SHVARTSBURG
Alex Shvartsburg
Chief Financial Officer

Livanova Plc

NASDAQ:LIVN

LIVN Rankings

LIVN Latest News

LIVN Latest SEC Filings

LIVN Stock Data

3.01B
54.41M
0.38%
103.73%
3.63%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United Kingdom
LONDON